Back to discover
Disease

Agranulocytosis

Late-stage therapeutic developmentEmerging research
MeSHAgranulocytosis
1
Publications
1
Clinical trials
1966
Latest publication
Latest activity
beta

Recent clinical, regulatory, research and industry developments relating to this disease.

What's happening now

An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.

No activity recorded in this window. Try a wider timeframe.

Clinical trials

1 sponsors · 0 new · 0 completed in the last 12 months (net +0)

The current development programme across all trial phases.

Clinical programme
1
All trials
0
Active
1
Late-stage
1
Completed
Late-stage studies

Comparison of Efficacy of Tranexamic Acid and Calcium Dobesilate for Bleeding of Endometrial Origin

Phase 2/3 · Completed · District Headquarters Teaching Hospital Sahiwal
Recently completed

Comparison of Efficacy of Tranexamic Acid and Calcium Dobesilate for Bleeding of Endometrial Origin

Phase 2/3 · Completed · District Headquarters Teaching Hospital Sahiwal

Research activity

1 papers

Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.

Major themes3
  • Leukocyte Count1
  • Leukopenia1
  • Lymphocytes1
Leading journals1
  • Annals of internal medicine1
Leading researchers4
  • Bodey GP1
  • Buckley M1
  • Freireich EJ1
  • Sathe YS1

Reference

Authoritative identity, definition & identifiers.

Defined in MeSH

A decrease in the number of GRANULOCYTES; (BASOPHILS; EOSINOPHILS; and NEUTROPHILS).

Identifiers
MeSHAgranulocytosis
References & data sources
  • Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
  • Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
  • Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
  • Related entities are derived from literature co-mention (studied together) — associative, not causal.